Sanford-Burnham hires GSK exec Nisen to boost pharma cache
This article was originally published in Scrip
Executive Summary
The Sanford-Burnham Medical Research Institute in San Diego hired Perry Nisen from GlaxoSmithKline as its new CEO to bring the institute some pharma and biotech cache – and cash – as Sanford-Burnham sets its new strategy in motion for translating research into drugs and diagnostics through revenue-generating industry partnerships.